Linked e-resources
Details
Table of Contents
Part I: Bacteriophages as antibacterialagents
Chapter 1:Production of PhageTherapeutics and Formulations
InnovativeApproaches
Chapter 2:Phagepharmacokinetics: relationship with administrationroute
Chapter 3:BacterialResistance to Phage and itsImpact on Clinical Therapy
Part II: Bacteriophages and the immune system
Chapter 4:Phageinteraction with the mammalianimmune system
Chapter 5:Humoralimmuneresponse to phage-basedtherapeutics
Part III:Use of bacteriophages to combat bacterial infections
Chapter 6:How to achieve a goodphage therapy clinical trial?
Chapter 7: Perspectives on the RenewedInterest in the United States
Chapter 8:Phage Therapy in Orthopaedic Implant-associated Infections
Chapter 9:The use of bacteriophages in animalhealth and food protection
Chapter 10:Combiningbacteriophages with otherantibacterialagents to combatbacteria
Chapter 11: Phage therapy of infectious biofilms: Challenges and strategies
Part IV:Phage therapy
regulatory and ethical aspects
Chapter 12:Regulatory Considerations for Bacteriophage Therapy Products
Chapter 13:Developing phagesintomedicines for Europe
Chapter 14: Phagetherapy in Europe: Regulatory and intellectualpropertyprotectionissues
Chapter 15:Ethics of phagetherapy
Part V: Bacteriophage-derived antibacterial agents
Chapter 16: NovelAlternative to Antibiotics.
Chapter 1:Production of PhageTherapeutics and Formulations
InnovativeApproaches
Chapter 2:Phagepharmacokinetics: relationship with administrationroute
Chapter 3:BacterialResistance to Phage and itsImpact on Clinical Therapy
Part II: Bacteriophages and the immune system
Chapter 4:Phageinteraction with the mammalianimmune system
Chapter 5:Humoralimmuneresponse to phage-basedtherapeutics
Part III:Use of bacteriophages to combat bacterial infections
Chapter 6:How to achieve a goodphage therapy clinical trial?
Chapter 7: Perspectives on the RenewedInterest in the United States
Chapter 8:Phage Therapy in Orthopaedic Implant-associated Infections
Chapter 9:The use of bacteriophages in animalhealth and food protection
Chapter 10:Combiningbacteriophages with otherantibacterialagents to combatbacteria
Chapter 11: Phage therapy of infectious biofilms: Challenges and strategies
Part IV:Phage therapy
regulatory and ethical aspects
Chapter 12:Regulatory Considerations for Bacteriophage Therapy Products
Chapter 13:Developing phagesintomedicines for Europe
Chapter 14: Phagetherapy in Europe: Regulatory and intellectualpropertyprotectionissues
Chapter 15:Ethics of phagetherapy
Part V: Bacteriophage-derived antibacterial agents
Chapter 16: NovelAlternative to Antibiotics.